Du Chunyang, Ren Yunzhuo, Yao Fang, Duan Jialiang, Zhao Hui'er, Du Yunxia, Xiao Xia, Duan Huijun, Shi Yonghong
Department of Pathology, Hebei Medical University, Shijiazhuang, China; Hebei Key Laboratory of Kidney Diseases, Shijiazhuang, China.
Department of Ophthalmology, Second Hospital, Hebei Medical University, Shijiazhuang, China.
Int J Biochem Cell Biol. 2017 Sep;90:17-28. doi: 10.1016/j.biocel.2017.07.011. Epub 2017 Jul 18.
Autophagy is an important homoeostatic mechanism for the lysosomal degradation of protein aggregates and damaged cytoplasmic components. Recent studies suggest that autophagy which is induced by TGF-β1 suppresses kidney fibrosis in renal tubular epithelial cells (RTECs) of obstructed kidneys. Sphingosine kinase 1(SK1), converting sphingosine into endogenous sphingosine-1-phosphate (S1P), was shown to modulate autophagy and involved in the processes of fibrotic diseases. Since SK1 activity is also up-regulated by TGF-β1, we explored its effect on the induction of autophagy and development of renal fibrosis in this study. In vitro, SK1 expression and activity were markedly increased by TGF-β1 stimulation in a time and concentration dependent manner, and concomitant changes in autophagic response were observed in HK-2 cells. Further, knockdown of SK-1 led to a decrease of autophagy whereas overexpression of SK1 caused a greater induction of autophagy. In addition, overexpression of SK1 resulted in decreased of mature TGF-β levels through autophagic degradation. In vivo, SK1 enzymatic activity and autophagic response were both up-regulated in a mouse model of kidney fibrosis induced by unilateral ureteral obstruction (UUO); meanwhile, increased of mature TGF-β1 and deposition of extracellular matrix (ECM) were observed in tubulointerstitial areas compared with sham-operated mice. However, aggravation of renal fibrosis was detected when SK1 inhibitor PF-543 was applied to suppress SK1 enzymatic activity in UUO mice. At the same time, autophagy was also inhibited by PF-543. Thus, our findings suggest that SK1 activation is renoprotective via induction of autophagy in the fibrotic process.
自噬是一种重要的稳态机制,用于溶酶体降解蛋白质聚集体和受损的细胞质成分。最近的研究表明,由转化生长因子-β1(TGF-β1)诱导的自噬可抑制梗阻性肾脏肾小管上皮细胞(RTECs)中的肾纤维化。鞘氨醇激酶1(SK1)可将鞘氨醇转化为内源性鞘氨醇-1-磷酸(S1P),已证明其可调节自噬并参与纤维化疾病的进程。由于SK1活性也受TGF-β1上调,因此我们在本研究中探讨了其对自噬诱导和肾纤维化发展的影响。在体外,TGF-β1刺激以时间和浓度依赖性方式显著增加SK1的表达和活性,并且在HK-2细胞中观察到自噬反应的伴随变化。此外,敲低SK-1导致自噬减少,而SK1的过表达引起更大程度的自噬诱导。此外,SK1的过表达通过自噬降解导致成熟TGF-β水平降低。在体内,在单侧输尿管梗阻(UUO)诱导的肾纤维化小鼠模型中,SK1酶活性和自噬反应均上调;同时,与假手术小鼠相比,在肾小管间质区域观察到成熟TGF-β1增加和细胞外基质(ECM)沉积。然而,当应用SK1抑制剂PF-543抑制UUO小鼠的SK1酶活性时,检测到肾纤维化加重。同时,PF-543也抑制自噬。因此,我们的研究结果表明,SK1激活在纤维化过程中通过诱导自噬具有肾脏保护作用。